IPCA Laboratories at PPFCF

Sat, 16 May 2026 00:00:00 +0000

Lead

IPCA Laboratories Limited is among the periodic pharmaceutical mid-cap holdings of the Parag Parikh Flexi Cap Fund (PPFCF). The position has appeared in PPFCF factsheet portfolio listings across multiple cycles, alongside other healthcare holdings such as Cipla at PPFCF .

The IPCA Laboratories thesis combines several elements of the broader PPFAS investment philosophy . First, specialty therapy-area leadership: IPCA has historically been one of India’s largest manufacturers of anti-malarial active pharmaceutical ingredients (APIs) and formulations and has built strong franchises in cardiovascular, pain management and rheumatology. Second, generics and branded formulations mix: the company operates a balanced revenue mix across regulated-market generics exports, semi-regulated and emerging markets and Indian branded formulations. Third, disciplined valuation-driven entry: the team has typically built or added to the position during cyclical compression windows.

IPCA Laboratories on WebNotes

IPCA Laboratories at PPFCF

Lead